{
    "Case ID": "087518",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent infringement dispute"
    ],
    "Legal_Issue": [
        "Whether the Plaintiffs can obtain an interim injunction for alleged patent infringement"
    ],
    "Governing_Law": [
        "Federal Courts Act, section 44",
        "Federal Court Rules, rule 374"
    ],
    "Procedural_Stage": [
        "Interim injunction motion"
    ],
    "Evidence_Assessment": [
        "Expert testimony on irreparable harm in Australia; lack of evidence on urgency in Canada"
    ],
    "Decision_Outcome": [
        "Interim injunction granted for Australia; denied for Canada"
    ],
    "Burden_of_Proof": [
        "Plaintiff bears burden to satisfy RJR-Macdonald test"
    ],
    "Credibility_Factor": [
        "Expert testimony deemed credible for Australian market harm"
    ],
    "Legal_Rule": [
        "RJR-Macdonald test: (a) serious issue to be tried, (b) irreparable harm, (c) balance of convenience"
    ],
    "Standard_of_Review": [
        "Interim injunction standard"
    ],
    "Procedural_Issue": [
        "Urgency not established for Canadian market"
    ],
    "Grounds_for_Claim": [
        "Alleged infringement of Canadian Patent No. 1,341,196 through manufacturing, selling, and exporting perindopril"
    ],
    "Outcome_on_Merits": [
        "Not decided; interim relief only"
    ],
    "Decision_Maker": [
        "Federal Court"
    ],
    "Judicial_Review_Outcome": [
        "Partial grant of interim injunction"
    ],
    "Review_Standard": [
        "Balance of convenience, irreparable harm, serious issue to be tried"
    ],
    "Procedural_Fairness_Assessment": [
        "Both parties presented evidence; Defendants provided 12-day notice undertaking"
    ],
    "Key_Evidence_Considered": [
        "Expert testimony on market impact in Australia; Defendants' marketing approval status in Canada"
    ],
    "Legal_Framework": [
        "Canadian patent law, interim injunctive relief framework"
    ],
    "Applicant_Challenge": [
        "Establishing urgency and irreparable harm in Canada"
    ],
    "Court_Result": [
        "Injunction granted for Australia, not for Canada"
    ],
    "Legal_Rule_Source": [
        "RJR-Macdonald test from Federal Court jurisprudence"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities for interim relief"
    ],
    "Defendant_Response": [
        "Provided 12-day notice undertaking not to launch in Canada without notice"
    ],
    "Evidence_Type": [
        "Documentary evidence, expert testimony"
    ],
    "Remedy_Requested": [
        "Interim injunction to prevent export and sale of perindopril"
    ],
    "Outcome": [
        "Partial interim injunction issued"
    ],
    "Decision_Authority": [
        "Federal Court of Canada"
    ],
    "Remedy_Sought": [
        "Prevention of infringing activities pending trial"
    ],
    "Resolution_Mechanism": [
        "Judicial determination on interim injunction motion"
    ],
    "Legal_Provision": [
        "Section 44 of the Federal Courts Act",
        "Rule 374 of the Federal Court Rules"
    ],
    "Authority": [
        "Federal Court"
    ],
    "Claimant_Status": [
        "Patent holder (Plaintiff)"
    ],
    "Legal_Provision_Cited": [
        "Federal Courts Act, s. 44",
        "Federal Court Rules, r. 374"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Alleged infringement of Canadian Patent No. 1,341,196"
    ],
    "Applicable_Process": [
        "Motion for interim injunction under Federal Court Rules"
    ],
    "Outcome_of_Review": [
        "Interim relief partially granted"
    ],
    "Pending_Relief_or_Application": [
        "Interim injunction application"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "RJR-Macdonald test for interim injunctions"
    ]
}